A multidisciplinary pediatric oncofertility team improves fertility preservation and counseling across 7 years.
fertility counseling
fertility preservation
oncofertility
pediatric oncology
quality improvement
Journal
Cancer reports (Hoboken, N.J.)
ISSN: 2573-8348
Titre abrégé: Cancer Rep (Hoboken)
Pays: United States
ID NLM: 101747728
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
revised:
20
09
2022
received:
18
05
2022
accepted:
13
10
2022
pubmed:
9
11
2022
medline:
25
2
2023
entrez:
8
11
2022
Statut:
ppublish
Résumé
Oncofertility is a developing field of increasing importance, particularly in pediatric oncology, where most patients are likely to survive long-term and have not yet had the opportunity to have children. We performed a quality improvement initiative to increase our rates of fertility preservation counseling and referral through the implementation of a pediatric oncofertility team, and we report outcomes 7 years following implementation of our initiative. We compare our baseline oncofertility survey to 44 post-intervention survey respondents and electronic medical record documentation for 149 patients treated in 2019. Ninety-five percent of post-intervention survey respondents recalled fertility counseling (baseline 70%, p = .004) and 89.3% were appropriately referred for fertility preservation (baseline 50%, p = .017). Counseling was documented in 60.4% of charts; 81% of patients analyzed by chart review were appropriately referred for fertility preservation. Fertility preservation outcomes differed by sex assigned at birth. Creation of an oncofertility team produced improvements in fertility counseling and fertility preservation referral across an extended period of time.
Sections du résumé
BACKGROUND
Oncofertility is a developing field of increasing importance, particularly in pediatric oncology, where most patients are likely to survive long-term and have not yet had the opportunity to have children.
AIMS
We performed a quality improvement initiative to increase our rates of fertility preservation counseling and referral through the implementation of a pediatric oncofertility team, and we report outcomes 7 years following implementation of our initiative.
METHODS AND RESULTS
We compare our baseline oncofertility survey to 44 post-intervention survey respondents and electronic medical record documentation for 149 patients treated in 2019. Ninety-five percent of post-intervention survey respondents recalled fertility counseling (baseline 70%, p = .004) and 89.3% were appropriately referred for fertility preservation (baseline 50%, p = .017). Counseling was documented in 60.4% of charts; 81% of patients analyzed by chart review were appropriately referred for fertility preservation. Fertility preservation outcomes differed by sex assigned at birth.
CONCLUSION
Creation of an oncofertility team produced improvements in fertility counseling and fertility preservation referral across an extended period of time.
Identifiants
pubmed: 36346013
doi: 10.1002/cnr2.1753
pmc: PMC9939996
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1753Informations de copyright
© 2022 The Authors. Cancer Reports published by Wiley Periodicals LLC.
Références
Chow EJ, Kamineni A, Daling JR, et al. Reproductive outcomes in male childhood cancer survivors: a linked cancer-birth registry analysis. Arch Pediatr Adolesc Med. 2009;163(10):887-894. doi:10.1001/archpediatrics.2009.111
Gnaneswaran S, Deans R, Cohn RJ. Reproductive late effects in female survivors of childhood cancer. Obstet Gynecol Int. 2012;2012:564794. doi:10.1155/2012/564794
Hudson MM. Reproductive outcomes for survivors of childhood cancer. Obstet Gynecol. 2010;116(5):1171-1183. doi:10.1097/AOG.0b013e3181f87c4b
Patel V, Jones P, Judd A, Senko V, Altieri G, Pettee D. Recollection of fertility discussion in adolescent and young adult oncology patients: a single-institution study. J Adolesc Young Adult Oncol. 2020;9(1):72-77. doi:10.1089/jayao.2019.0075
Brancati S, Gozzo L, Longo L, Vitale DC, Russo G, Drago F. Fertility preservation in female pediatric patients with cancer: a clinical and regulatory issue. Front Oncol. 2021;11:641450. doi:10.3389/fonc.2021.641450
Oktay K, Harvey BE, Loren AW. Fertility preservation in patients with cancer: ASCO clinical practice guideline update summary. J Oncol Pract. 2018;14(6):381-385. doi:10.1200/JOP.18.00160
Klipstein S, Fallat ME, Savelli S. Fertility preservation for pediatric and adolescent patients with cancer: medical and ethical considerations. Pediatrics. 2020;145(3). doi:10.1542/peds.2019-3994
Neuss MN, Malin JL, Chan S, et al. Measuring the improving quality of outpatient care in medical oncology practices in the United States. J Clin Oncol. 2013;31(11):1471-1477. doi:10.1200/JCO.2012.43.3300
Zarnegar S, Gosiengfiao Y, Rademaker A, Casey R, Albritton KH. Recall of fertility discussion by adolescent female cancer patients: a survey-based pilot study. J Adolesc Young Adult Oncol. 2018;7(2):249-253. doi:10.1089/jayao.2017.0079
Moravek MB, Appiah LC, Anazodo A, et al. Development of a pediatric fertility preservation program: a report from the pediatric initiative network of the oncofertility consortium. J Adolesc Health. 2019;64(5):563-573. doi:10.1016/j.jadohealth.2018.10.297
Sheth KR, Sharma V, Helfand BT, et al. Improved fertility preservation care for male patients with cancer after establishment of formalized oncofertility program. J Urol. 2012;187(3):979-986. doi:10.1016/j.juro.2011.10.154
Lewin J, Ma JMZ, Mitchell L, et al. The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation options. Support Care Cancer. 2017;25(6):1915-1922. doi:10.1007/s00520-017-3597-8
Frederick NN, Klosky JL, Meacham LR, et al. Infrastructure of fertility preservation services for pediatric cancer patients: a report from the Children's oncology group. JCO Oncol Pract. 2022;18(3):e325-e333. doi:10.1200/op.21.00275
Behl S, Joshi VB, Hussein RS, et al. Consult and procedure incidence outcomes following establishment of a fertility preservation program for children with cancer. J Assist Reprod Genet. 2021;38(2):495-501. doi:10.1007/s10815-020-02042-8
Lehmann V, Kutteh WH, Sparrow CK, Bjornard KL, Klosky JL. Fertility-related services in pediatric oncology across the cancer continuum: a clinic overview. Support Care Cancer. 2020;28(8):3955-3964. doi:10.1007/s00520-019-05248-4
Dorfman CS, Stalls JM, Mills C, et al. Addressing barriers to fertility preservation for cancer patients: the role of oncofertility patient navigation. J Oncol Navig Surviv. 2021;12(10):332-348.
Hayashi M, Albert CM, Gubin A, et al. Onco-fertility care in a children's hospital: a quality improvement initiative. J Clin Oncol. 2013;31(31_suppl):41. doi:10.1200/jco.2013.31.31_suppl.41
Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4831-4841. doi:10.1200/JCO.2009.22.8312
Resetkova N, Hayashi M, Kolp LA, Christianson MS. Fertility preservation for Prepubertal girls: update and current challenges. Curr Obstet Gynecol Rep. 2013;2(4):218-225. doi:10.1007/s13669-013-0060-9
Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677-2685. doi:10.1200/JCO.2008.20.1541
Moore HC, Unger JM, Phillips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372(10):923-932. doi:10.1056/NEJMoa1413204
Demeestere I, Brice P, Peccatori FA, et al. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016;34(22):2568-2574. doi:10.1200/JCO.2015.65.8864
Quaas AM, Ginsburg ES. Prevention and treatment of uterine bleeding in hematologic malignancy. Eur J Obstet Gynecol Reprod Biol. 2007;134(1):3-8. doi:10.1016/j.ejogrb.2007.03.012
Meirow D, Rabinovici J, Katz D, Or R, Shufaro Y, Ben-Yehuda D. Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer. 2006;107(7):1634-1641. doi:10.1002/cncr.22199
Salsman JM, Yanez B, Smith KN, et al. Documentation of fertility preservation discussions for young adults with cancer: examining compliance with treatment guidelines. J Natl Compr Canc Netw. 2016;14(3):301-309. doi:10.6004/jnccn.2016.0035
Quinn GP, Block RG, Clayman ML, et al. If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients' medical records. J Oncol Pract. 2015;11(2):137-144. doi:10.1200/jop.2014.000786
Lehmann V, Chemaitilly W, Lu L, et al. Gonadal functioning and perceptions of infertility risk among adult survivors of childhood cancer: a report from the St Jude lifetime cohort study. J Clin Oncol. 2019;37(11):893-902. doi:10.1200/JCO.18.00965
Klosky JL, Wang F, Russell KM, et al. Prevalence and predictors of sperm banking in adolescents newly diagnosed with cancer: examination of adolescent, parent, and provider factors influencing fertility preservation outcomes. J Clin Oncol. 2017;35(34):3830-3836. doi:10.1200/JCO.2016.70.4767
Meacham LR, Burns K, Orwig KE, Levine J. Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the pediatric initiative network risk stratification system. J Adolesc Young Adult Oncol. 2020;9(6):662-666. doi:10.1089/jayao.2020.0012
Practice Committee of the American Society for reproductive medicine. Electronic address aao. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion. Fertil Steril. 2019;112(6):1022-1033. doi:10.1016/j.fertnstert.2019.09.013
von Wolff M, Andersen CY, Woodruff TK, Nawroth F. FertiPROTEKT, oncofertility consortium and the Danish fertility-preservation networks - what can we learn from their experiences? Clin Med Insights Reprod Health. 2019;13:1179558119845865. doi:10.1177/1179558119845865
Woodruff TK, Ataman-Millhouse L, Acharya KS, et al. A view from the past into our collective future: the oncofertility consortium vision statement. J Assist Reprod Genet. 2021;38(1):3-15. doi:10.1007/s10815-020-01983-4
Practice Committee of the Oncofertility C. Installing oncofertility programs for common cancers in optimum resource settings (repro-can-OPEN study part II): a committee opinion. J Assist Reprod Genet. 2021;38(1):163-176. doi:10.1007/s10815-020-02012-0
Ataman LM, Rodrigues JK, Marinho RM, et al. Creating a global Community of Practice for Oncofertility. JCO Glob Oncol. 2020;6:317-330. doi:10.1200/GO.22.00007
Salama M, Ataman L, Taha T, et al. Building Oncofertility Core competency in developing countries: experience from Egypt, Tunisia, Brazil, Peru, and Panama. JCO Glob Oncol. 2020;4:6-11. doi:10.1200/JGO.17.00121
Appiah L, Anazodo A, Salama M, et al. Inclusion and diversity in oncofertility care. J Adolesc Young Adult Oncol. 2021;10(2):120-126. doi:10.1089/jayao.2021.29006.rdt
Scovell JM, Benz K, Samarska I, et al. Association of impaired spermatogenesis with the use of immune checkpoint inhibitors in patients with metastatic melanoma. JAMA Oncologia. 2020;6(8):1297-1299. doi:10.1001/jamaoncol.2020.1641
Rabinowitz MJ, Kohn TP, Pena VN, Samarska IV, Matoso A, Herati AS. Onset of azoospermia in man treated with ipilimumab/nivolumab for BRAF negative metastatic melanoma. Urol Case Rep. 2021;34:101488. doi:10.1016/j.eucr.2020.101488
Ligon JA, Fry A, Maher JY, et al. Fertility and CAR T-cells: current practice and future directions. Transplant Cell Ther. 2022;28(9):605 e1-605 e8. doi:10.1016/j.jtct.2022.06.002